Español
EnglishDiscovery and development of compounds that help to modify the progression of neurological and/or neurodegenerative diseases, particularly in the Alzheimer’s disease
Pharma Division
- Home
- Pharma Division
Approaches this kind of diseases focusing on the early stages of them, pointing out innovative therapeutic targets supported by translational research. This strategy is a distinctive feature compared to research lines developed by pharmaceutical companies to date.
There are 5 new patented neuroprotective compounds against Alzheimer’s and epilepsy in its portfolio that belong to three different pharmacological groups. It also has a broad molecule and high-value added microbial extracts collection (>22,000).
Furthermore, Neuron Bio has developed a drug discovery and development platform that brings together more than 50 differentiating technologies.
